Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001783 · ClinicalTrials.gov registry record · Phase 2
Motor Recovery in Recent Stroke Patients Treated With Amphetamine and Physical Therapy
A Phase 2 study of Cerebrovascular Accident and Paralysis, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- Phase 2
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT00001783: Completed Phase 2 study of Cerebrovascular Accident and Paralysis, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00001783 is a Phase 2 study of Cerebrovascular Accident and Paralysis that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 34 participants, below the 517-participant average among 26 other Cerebrovascular Accident trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001783, a Phase 2 study of Cerebrovascular Accident and Paralysis, has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if giving amphetamines along with standard rehabilitation speeds motor recovery after a stroke. In addition, if motor recovery is improved, the study will also identify the areas of the brain involved with the recovery. Researchers will use motor function ratings, PET scans, functional MRI (fMRI), electroencephalographs, and transcranial magnetic stimulation (TMS) to evaluate patients. Patients participating in the study will be placed in one of two groups; 1. Patients receiving dextroamphetamine and routine Rehabilitation Medicine 2. Patients receiving a placebo "sugar pill" and routine Rehabilitation Medicine Patients that have improved motor recovery will undergo neuroimaging and neurophysiological studies to identify areas of the brain involved.
Conditions Studied
Interventions
- DRUG 0-15 Water
Study Locations (1)
Maryland
- National Institute of Neurological Disorders and Stroke (NINDS) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 1998-04 |
| Est. Completion | 2004-06 |
| Phase | Phase 2 |
What the finished NCT00001783 record still lists
NCT00001783 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 517-participant average among 26 other Cerebrovascular Accident trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Cerebrovascular Accident appearing as the primary indexed condition, and to 1 intervention - of which 0-15 Water is the first listed.
NCT00001783 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001783 about?
NCT00001783 is a clinical study titled "Motor Recovery in Recent Stroke Patients Treated With Amphetamine and Physical Therapy". The purpose of this study is to determine if giving amphetamines along with standard rehabilitation speeds motor recovery after a stroke. In addition, if motor recovery is improved, the study will also identify the areas of the brain involved with the recovery. Researchers will use motor function r...
What is the current status of trial NCT00001783?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 1998-04. Estimated completion is 2004-06.
What conditions does trial NCT00001783 study?
This clinical trial studies the following conditions: Cerebrovascular Accident, Paralysis.
What interventions are being tested in trial NCT00001783?
The interventions under investigation include: 0-15 Water (DRUG).
Who is sponsoring clinical trial NCT00001783?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001783 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebrovascular Accident
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00001783's enrollment target sits among peer trials
34 19th of 26 higher than 8 of 26 other Cerebrovascular Accident trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cerebrovascular Accident trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dietary Nitrate Supplements and Ischemic Stroke Recovery
COMPLETED · Phase 2
-
ReoPro and Retavase to Treat Acute Stroke
COMPLETED · Phase 2
-
Home-based Telehealth Stroke Care: A Randomized Trial for Veterans
COMPLETED · Phase 2
-
Stroke Rehabilitation Outcomes With Supported Treadmill Ambulation Training
COMPLETED · Phase 2
-
Combining Armodafinil With Neuro-rehabilitation to Improve Neurological Recovery and Reduce Disability Post-Stroke
COMPLETED · Phase 2
-
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia